Patrick Sullivan, MD, FRANZCP, the Yeargan Distinguished Professor of Psychiatry and Genetics at the UNC School of Medicine, and researchers at the Karolinska Institutet in Stockholm, Sweden, have developed a comprehensive ...
Aug 2, 2024
0
27
Antipsychotic drugs—used to treat the millions of people in the U.S. with schizophrenia—have lots of unpleasant side effects. The drugs also aren't effective for many people. There is an urgent need to develop better ...
Jul 18, 2023
0
263
Antipsychotic drugs are used to treat and manage symptoms of many psychiatric disorders, but their mechanisms of action remain a mystery. FMI researchers have found that antipsychotics reduce long-range communication within ...
Jul 18, 2023
0
1
For decades there has been almost no improvement in the medical treatment of schizophrenia, one of the most serious and devastating of all mental illnesses, but recent advances have raised hopes of progress.
May 30, 2023
0
22
Targeting calcium signaling in neurons represents a promising therapeutic approach for treating a rare form of schizophrenia, according to a Northwestern Medicine study published in Biological Psychiatry.
Feb 7, 2023
0
87
U.S. health officials say they plan to investigate whether some nursing homes are falsely labeling patients as schizophrenic so they can administer sedating antipsychotic drugs to them.
Jan 18, 2023
0
4
Inflammation and overactivation of the immune system in the brain can cause loss of synapses and the death of neurons, leading to neurodegenerative and psychiatric diseases.
Dec 22, 2022
0
4
Researchers at the Lieber Institute for Brain Development (LIBD) believe they have solved a riddle that has challenged scientists for more than 70 years: how the brain chemical dopamine relates to schizophrenia, the often-devastating ...
Nov 1, 2022
0
126
Over the last 15 years, researchers at the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard have been working to decode the biological causes of schizophrenia, which affects 20 million people ...
Apr 7, 2022
0
6
Repetitive transcranial magnetic stimulation (rTMS) was associated with a reduction in self-reported cannabis use by up to 60% among people with schizophrenia who have cannabis use disorder (CUD), according to a CAMH-led ...
Mar 4, 2022
1
13
